These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37691223)

  • 1. An Exploration of Some Predictors of Quality of Life-Related to the Innate Immune System, Inflammation, and Disease Activity in Patients with Behcet's Syndrome: An Analytical Cross-sectional Study.
    Faghfouri AH; Shoura SMS; Papi S; Khabbazi A; Baradaran B; Badpeyma M; Faghfuri E
    Curr Rheumatol Rev; 2024; 20(2):200-207. PubMed ID: 37691223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial.
    Faghfouri AH; Khabbazi A; Baradaran B; Khajebishak Y; Baghbani E; Noorolyai S; Rahmani S; Seyyed Shoura SM; Alipour M; Alipour B
    Clin Nutr; 2022 May; 41(5):1083-1092. PubMed ID: 35413570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of the Persian version of Behçet's disease quality-of-life (BD-QoL) questionnaire: a cross-cultural adaptation.
    Vojdanian M; Faezi ST; Tennant A; Morgan AW; Paragomi P; Qorbani M; Mattaji M; Davatchi F
    Rheumatol Int; 2015 Apr; 35(4):677-84. PubMed ID: 25216713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.
    Can Sandikci S; Colak S; Omma A; Enecik ME
    Int J Rheum Dis; 2019 Jun; 22(6):974-979. PubMed ID: 30398004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
    Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
    Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between serum IL-9 levels and Behçet's disease.
    Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
    Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.
    Neves FS; Carrasco S; Goldenstein-Schainberg C; Gonçalves CR; de Mello SB
    Clin Rheumatol; 2009 Dec; 28(12):1403-10. PubMed ID: 19701803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Arabic version of the Behçet's Disease Current Activity Form (Ar-BDCAF): cross-cultural adaptation and validation initiative in Egypt.
    Gheita TA; Fathi HM; Eesa NN; El-Shebini E; Tharwat S; Hammam N; Fawzy RM; El-Shereef RR; Abd El-Samea MH; Abdel Noor RA; Salem MN;
    Clin Rheumatol; 2021 Nov; 40(11):4609-4618. PubMed ID: 34170444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease.
    Shahram F; Khabbazi A; Nadji A; Ziaie N; Banihashemi AT; Davatchi F
    Mod Rheumatol; 2009; 19(5):536-41. PubMed ID: 19590934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of DNA methylation status of toll-like receptors 2 and 4 promoters in Behcet's disease.
    Kolahi S; Rashtchizadeh N; Mahdavi AM; Farhadi J; Khabbazi A; Sakhinia E; Bahavarnia N; Farajzadeh Polsangi MJ; Babaloo Z; Estiar MA
    J Gene Med; 2020 Oct; 22(10):e3234. PubMed ID: 32449979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease.
    Do JE; Kwon SY; Park S; Lee ES
    Rheumatology (Oxford); 2008 Jun; 47(6):840-8. PubMed ID: 18411217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation and validation of the Behcet's Disease Current Activity Form in Korea.
    Choi HJ; Seo MR; Ryu HJ; Baek HJ
    Korean J Intern Med; 2015 Sep; 30(5):714-8. PubMed ID: 26354066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The performance of different classification criteria in paediatric Behçet's disease.
    Batu ED; Sönmez HE; Sözeri B; Butbul Aviel Y; Bilginer Y; Özen S
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):119-123. PubMed ID: 28406761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and reliability of a Behcet's Syndrome Activity Scale in Korea.
    Choi HJ; Seo MR; Ryu HJ; Baek HJ
    Korean J Intern Med; 2016 Jan; 31(1):170-5. PubMed ID: 26767871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
    Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
    J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of TLR2 gene polymorphisms with ocular Behcet's disease in a Chinese Han population.
    Fang J; Hu R; Hou S; Ye Z; Xiang Q; Qi J; Zhou Y; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8384-92. PubMed ID: 24255044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of treatment adherence in patients with Behçet's disease: its relation to disease manifestations, patients' beliefs about medications, and quality of life.
    Zayed HS; Medhat BM; Seif EM
    Clin Rheumatol; 2019 Mar; 38(3):761-768. PubMed ID: 30367312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of recall of the items included in disease activity forms of Behçet's disease: comparison of retrospective questionnaires with a daily telephone interview.
    Simsek I; Meric C; Erdem H; Pay S; Kilic S; Dinc A
    Clin Rheumatol; 2008 Oct; 27(10):1255-60. PubMed ID: 18446267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience.
    De Luca G; Cariddi A; Campochiaro C; Vanni D; Boffini N; Tomelleri A; Cavalli G; Dagna L
    Rheumatology (Oxford); 2020 Jan; 59(1):171-175. PubMed ID: 31280296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.